—
C+
C+ The full Closelook — membership. Open the C+ overview

Ansell Ltd (ANN.AU) — the peer cohort

As of 2026-09-18 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Ansell Ltd ranks 2 of 10 in its cohort on the Closelook composite (63/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
ANN.AU Ansell Ltd 63 91 46 54 ok 0.8%
ISRG Intuitive Surgical Inc 57 18 76 24 neutral 36.5%
YPSN.SW Ypsomed Holding AG 55 63 62 30 info 17.5%
AFX.DE Carl Zeiss Meditec AG 51 52 35 58 bear 38.6%
TECN.SW Tecan Group AG 49 96 26 56 ok 1.4%
MMED MiniMed Group, Inc. Common Stock 46 84 20 25 — —
EL.PA EssilorLuxottica S. A. 44 6 46 61 bear 55.3%
RHC.AU Ramsay Health Care Ltd 45 91 22 53 ok 1.1%
TLX.AU TELIX Pharmaceuticals Ltd 39 89 27 17 ok 2.6%
BION.SW BB Biotech AG 74 74 96 81 info 8.2%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-18

Quick answers

Who are Ansell Ltd's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: Intuitive Surgical Inc (ISRG), Ypsomed Holding AG (YPSN.SW), Carl Zeiss Meditec AG (AFX.DE), Tecan Group AG (TECN.SW), MiniMed Group, Inc. Common Stock (MMED), EssilorLuxottica S. A. (EL.PA), Ramsay Health Care Ltd (RHC.AU), TELIX Pharmaceuticals Ltd (TLX.AU) and others.

How does ANN.AU score against its peers?

Ansell Ltd's composite reads 63/100, ranking 2 of 10 in its cohort as of 2026-09-18; the cohort's highest composite is BB Biotech AG at 74/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Medical Instruments & Supplies. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.